Form 8-K Werewolf Therapeutics, For: Aug 14
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Werewolf Therapeutics sells platform assets to EMD Serono for $33M
August 20, 2026 4:12 PM EDTWerewolf Therapeutics (NASDAQ: HOWL) sold its pre-clinical INDUCER platform and portions of its INDUKINE platform to EMD Serono Research & Development Institute Inc. on Aug. 14, 2026, under an asset purchase agreement.
Under the terms of the agreement, EMD Serono agreed to pay $28.0 million upfront, with... More
